The forecast for antiinfective medicine sales in Italy indicates a consistent decline from 2024 to 2028, with per capita spending decreasing annually from $44.7 in 2024 to $41.5 in 2028. This represents a year-on-year decrease of approximately 1.8%. Compared to 2023, when the value stood at $45.5 per capita, the compound annual growth rate (CAGR) over the five-year period is negative, reflecting a steady downward trend.

Future trends to watch for:

Increasing emphasis on preventive healthcare and vaccinations, potentially reducing the need for antiinfective medications.
Potential market shifts due to advances in antibiotic alternatives and stringent regulatory measures combating antibiotic resistance.
Economic factors and pharmaceutical policy changes impacting healthcare spending and resource allocation.